In 2020, the pharmaceutical industry graduates pay report came out!

"Pharmaceutical Network Industry Dynamics" recently, "2020 first-tier cities (Beijing, Shanghai, Guangzhou, Shenzhen) graduates pay report" published, the report investigated into the high-tech industry, financial industry, real estate industry, automotive industry, pharmaceutical industry, chemical industry, manufacturing industry, logistics industry, fast-disappearing industry, service industry fresh graduates pay level, graduates pay growth rate the next year, graduates the next year turnover rate and other data.
2020, the pharmaceutical industry graduates' pay report (Photo: Pharmaceutical Network) overall, compared with other industries, the pharmaceutical industry graduates' pay increases continue to rise.
but the salary levels of graduates with different majors and different degrees still have a big gap in some respects.
specifically, in the pharmaceutical industry starting point: 5722 yuan, undergraduate 7044 yuan, master's 9942 yuan, ph.D. and above 14493 yuan.
5th with an annual salary growth rate of 11.9 per cent.
in the 12 sectors, the company's turnover rate bottomed out at 8.4 per cent.
industry analysts believe that the report to the survival crisis of the pharmaceutical people actually brought a certain amount of confidence.
because wages in the pharmaceutical industry are still rising at a high level compared to other industries, "money" is still there, and the turnover rate is relatively low, it also shows that the pharmaceutical industry is still a better choice for employment.
it is worth noting that in 2020 the first-tier city pharmaceutical graduates turnover rate is relatively low, but industry analysis, to some extent, the pharmaceutical industry is still in the winter.
fact, in recent years by the volume of procurement, graded diagnosis and treatment series policy, health insurance payment reform and a series of policy factors, drug companies have been more frequent mobility of personnel.
first half of this year, a number of pharmaceutical companies announced layoffs, pay cuts and other news.
such as a domestic pharmaceutical company has previously announced the dissolution of a product line due to operating pressure, the abolition of more than 50 people.
another pharmaceutical company in order to reduce the company's cash flow, ease the company's operating difficulties, the study decided to reduce the short-term remuneration of all full-time employees.
, executives, middle-level and grass-roots staff were reduced by 20%, 15% and 10%, respectively, and employees who did not agree to pay cuts were removed from their posts on the ground.
of course, if there are layoffs and pay cuts, there will be an increase in recruitment.
There are also many pharmaceutical enterprises in encouraging pharmaceutical representatives to re-create value, such as repositioning sales staff responsibilities, evaluating sales incentive plans, adjusting sales staff solid float ratio, etc. to guide more compliant sales behavior, the main direction is to reduce floating compensation (sales bonus) accounted for the proportion of total cash compensation, in the assessment of sales reached and other quantitative indicators, at the same time, increase behavior assessment indicators and weight is also the direction of enterprises in the assessment of sales staff bonuses.
as a whole, the industry agrees that the personnel adjustment and salary adjustment of pharmaceutical enterprises are the inevitable result of the drastic changes in the pharmaceutical industry pattern and the reshapeing trend of the pharmaceutical market.
In recent years, the pharmaceutical reform has been deepening, in the pharmaceutical bidding and bidding price reduction, the state focus on monitoring the introduction of rational drug use drug catalog, "4 plus 7" drug belt procurement expansion, the new version of the national medical insurance drug catalog adjustment and many other policies frequently, the pharmaceutical industry is in a major transformation, the traditional business model has been unable to adapt to the new industry ecology.
, enterprises are not only facing public hospitals, but also private hospitals, pharmacies, and even online medical care, which requires a different business idea.
many companies have not been involved in so many areas before, and now under competitive pressure must expand their business ideas.
new situation needs new positions, also need new managers, some positions have to be replaced, pay and so on also need to be adjusted.
background, in order to obtain high wages, future pharmaceutical workers still have to strengthen their competitiveness, including upgrading vocational skills, analysis and interpretation of policies and pharmaceutical academic information.